Search Results - "Khatri, Ismat"
-
1
Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
Published in Cell reports (Cambridge) (29-12-2015)“…Although dendritic cell (DC) dysfunction in cancer is a well-recognized consequence of cancer-associated inflammation that contributes to immune evasion, the…”
Get full text
Journal Article -
2
Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model
Published in PloS one (24-02-2017)“…Cell-surface CD200 expression by mouse EMT6 breast tumor cells increased primary tumor growth and metastasis to the draining lymph nodes (DLN) in normal (WT)…”
Get full text
Journal Article -
3
Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells
Published in Journal for immunotherapy of cancer (01-09-2023)“…Background Patients with relapsed/refractory T-cell malignancies have limited treatment options. The use of chimeric antigen receptor (CAR)-T cell therapy for…”
Get full text
Journal Article -
4
Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy
Published in PloS one (19-11-2014)“…We have compared cure from local/metastatic tumor growth in BALB/c mice receiving EMT6 or the poorly immunogenic, highly metastatic 4THM, breast cancer cells…”
Get full text
Journal Article -
5
Characterization of CD200 Ectodomain Shedding
Published in PloS one (25-04-2016)“…We have previously reported the existence of a soluble form of CD200 (sCD200) in human plasma, and found sCD200 to be elevated in the plasma of Chronic…”
Get full text
Journal Article -
6
Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression
Published in Leukemia research (01-07-2013)“…Abstract CD200, a membrane glycoprotein of the immunoglobulin superfamily, is overexpressed in CLL. Soluble in serum CD200 (sCD200) is correlated with poor…”
Get full text
Journal Article -
7
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
Published in Molecular therapy. Nucleic acids (07-09-2018)“…Functional aptamers displaying agonistic or antagonistic properties are showing great promise as modulators of immune responses. Here, we report the…”
Get full text
Journal Article -
8
The role of CD200 in immunity to B cell lymphoma
Published in Journal of leukocyte biology (01-08-2010)“…CD200 expression on lymphoma/CLL cells, or in CLL serum, suppresses immunity yet is overcome by neutralizing antibody, siRNAs, or absorption of CD200 from…”
Get full text
Journal Article -
9
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
Published in Molecular therapy. Nucleic acids (01-08-2014)“…CD200R1 expressed on the surface of myeloid and lymphoid cells delivers immune inhibitory signals to modulate inflammation when engaged with its ligand CD200…”
Get full text
Journal Article -
10
Peptides of CD200 Modulate LPS-Induced TNF-α Induction and Mortality In Vivo
Published in The Journal of surgical research (01-03-2008)“…Interaction of the ubiquitously expressed molecule CD200 with its receptor(s) CD200R, expressed on cells of myeloid and lymphoid origin, delivers…”
Get full text
Journal Article -
11
Identification of an Expressed Truncated Form of CD200, CD200tr, which is a Physiologic Antagonist of CD200-Induced Suppression
Published in Transplantation (27-10-2008)“…Earlier studies have indicated that cell surface expressed CD200, or a soluble form of this molecule, can induce immunosuppression in a number of biological…”
Get full text
Journal Article -
12
N-linked oligosaccharides play a role in disulphide-dependent dimerization of intestinal mucin Muc2
Published in Biochemical journal (01-08-2003)“…Within the C-terminal domain of many secretory mucins is a 'cystine knot' (CK), which is needed for dimer formation in the endoplasmic reticulum. Previous…”
Get full text
Journal Article -
13
C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components
Published in Biochemical journal (01-09-2002)“…Although human MUC3 and rodent Muc3 are both membrane-associated intestinal mucins, the present study has explored the possibility that rodent Muc3 might exist…”
Get full text
Journal Article -
14
SEA (sea-urchin sperm protein, enterokinase and agrin)-module cleavage, association of fragments and membrane targeting of rat intestinal mucin Muc3
Published in Biochemical journal (15-05-2003)“…In a previous study we showed, by transient expression studies in COS-1 cells, that the C-terminal domain of rat intestinal membrane mucin Muc3 was cleaved…”
Get full text
Journal Article -
15
A comparison of the biological properties of small molecular weight agonists and antagonists of CD200:CD200R interactions
Published in Medicinal chemistry (Shp-sariqah, United Arab Emirates) (01-11-2008)“…Our laboratory and others have documented in some detail the immunological consequences which follow from interaction of the ubiquitously expressed molecule…”
Get more information
Journal Article -
16
Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients
Published in Pediatric research (01-04-2003)“…Cystic fibrosis (CF) patients develop chronic lung infections associated with airway obstruction by viscous and insoluble mucus secretions. Although mucus…”
Get full text
Journal Article -
17
-
18
Evidence for a second peptide cleavage in the C-terminal domain of rodent intestinal mucin Muc3
Published in Biochemical journal (15-02-2004)“…Rat intestinal mucin Muc3 (rMuc3), like its human homologue (MUC3) and several other membrane mucins, contains a C-terminally located SEA (sea urchin sperm…”
Get full text
Journal Article -
19
Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities
Published in Science immunology (22-04-2022)“…The development of autologous chimeric antigen receptor T (CAR-T) cell therapies has revolutionized cancer treatment. Nevertheless, the delivery of CAR-T cell…”
Get more information
Journal Article -
20
Immunization of CD200R1KO mice post surgical resection of EMT6 breast cancer leads to long-term (>1year) cure of metastatic tumor growth (TUM2P.1022)
Published in The Journal of immunology (1950) (01-05-2015)“…Abstract Attenuated expression of CD200 decreases local tumor growth and metastasis in immunocompetent animals. We explored the ability to cure BALB/c CD200KO…”
Get full text
Journal Article